Concepedia

Ruifeng Xue

RX

11

Publications

321

Citations

11

H-Index

2009

Active since

Affiliations

Peking University(Current)

Peking University Cancer Hospital

Sun Yat-sen University

Nanjing Drum Tower Hospital

Ministry of Education

Ruifeng Xue is an author at Peking University specializing in pathology, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2009–2024

11

Publications

11

Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell Lymphoma

Ruonan Shao, Chengcheng Liu, Ruifeng Xue et al. · International Journal of Biological Sciences · 2024 · 64 citations · Full text

Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Jiayong Liu, Tian Gao, Zhichao Tan et al. · Clinical Cancer Research · 2022 · 39 citations · Full text

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition

Yuan Zhou, Ruifeng Xue, Jinglin Wang et al. · Brazilian Journal of Medical and Biological Research · 2020 · 37 citations · Full text

, , +19

KIF18B promotes tumor progression in osteosarcoma by activating β-catenin

Tian Gao, Ling Yu, Zhiwei Fang et al. · Cancer Biology and Medicine · 2020 · 37 citations · Full text

, , +13

Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3/miR-34a/NF-κB in primary liver cancer.

Yuheng Zhang, Haozhen Ren, Jun Li et al. · PubMed · 2021 · 34 citations · Full text

Rows per page

1–5 of 11